Literature DB >> 17217149

Increased QT dispersion: a negative prognostic finding in chronic obstructive pulmonary disease.

Roberto Zulli1, Paolo Donati, Franco Nicosia, Massimiliano De Vecchi, Claudio Tantucci, Giuseppe Romanelli, Vittorio Grassi.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a highly prevalent syndrome, deeply affecting the cardiovascular system as well as the lungs. We investigated the prognostic role of the QT interval and QT dispersion (QTD) in predicting all-cause, respiratory and cardiovascular mortality in COPD, and the relationship between these electrocardiographic parameters and pulmonary function in a prospective longitudinal study.
METHODS: We studied 246 COPD patients without significant co-morbidities, with a mild to moderate functional impairment, admitted to the Department of Internal Medicine from January 1995 to December 2001, performing a 5-year mean follow-up (5-116 months) up to August 2004. After clinical stabilisation, an electrocardiogram and functional respiratory tests were obtained, allowing measurement of the QT interval and QTD, forced vital capacity (FVC), forced expiratory volume at 1 s (FEV1), inspiratory capacity, FEV1/FVC ratio, partial oxygen pressure and partial carbon dioxide pressure in arterial blood.
RESULTS: At the end of the follow-up period, 81 patients were dead, 165 still alive; 36 died because of respiratory causes, 23 because of cardio-cerebrovascular events, 21 because of cancer (mainly lung cancer). A significant high incidence of sudden cardiac death was observed. QTD and QTcD showed a significant relationship with respiratory functional parameters. Maximal QT interval, QTcD and QTD appear to be independent predictors of all-cause, cardiovascular and respiratory mortality (relative risk 1.94, 3.22, 2.88, respectively). Age > 65 years, partial oxygen pressure < 60 mmHg and inspiratory capacity < 80% of the predicted value were the only other independent predictive parameters.
CONCLUSIONS: Maximal QT interval, QTD and QTcD are independent predictors of mortality. A significant incidence of cardiac sudden death was observed. These findings suggest the need for a global and multidisciplinary risk assessment in COPD patients. Intriguing relationships between the QTD and functional respiratory parameters were also observed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217149     DOI: 10.1007/BF02934761

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  30 in total

1.  Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease.

Authors:  S Scalvini; R Porta; E Zanelli; M Volterrani; M Vitacca; M Pagani; A Giordano; N Ambrosino
Journal:  Eur Respir J       Date:  1999-01       Impact factor: 16.671

2.  Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart.

Authors:  M Zabel; P R Lichtlen; A Haverich; M R Franz
Journal:  J Cardiovasc Electrophysiol       Date:  1998-12

3.  Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans.

Authors:  D G Kiely; R I Cargill; B J Lipworth
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

4.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

5.  Marked sympathetic activation in patients with chronic respiratory failure.

Authors:  S Heindl; M Lehnert; C P Criée; G Hasenfuss; S Andreas
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

6.  Precordial QT dispersion and inducible ventricular tachycardia.

Authors:  K W Lee; P M Okin; P Kligfield; K M Stein; B B Lerman
Journal:  Am Heart J       Date:  1997-12       Impact factor: 4.749

7.  The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD.

Authors:  A G Stewart; J C Waterhouse; P Howard
Journal:  Respir Med       Date:  1995-02       Impact factor: 3.415

8.  Effects of aging and of chronic obstructive pulmonary disease on RR interval variability.

Authors:  M Pagani; D Lucini; P Pizzinelli; M Sergi; E Bosisio; G S Mela; A Malliani
Journal:  J Auton Nerv Syst       Date:  1996-07-05

9.  Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; P Howard
Journal:  Eur Respir J       Date:  1991-11       Impact factor: 16.671

10.  Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease.

Authors:  W Zareba; A J Moss; S le Cessie
Journal:  Am J Cardiol       Date:  1994-09-15       Impact factor: 2.778

View more
  10 in total

1.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

Review 2.  QT dispersion: time for a revival?

Authors:  Alessandro Celi
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.

Authors:  Hilary F Armstrong; Gina S Lovasi; Elsayed Z Soliman; Susan R Heckbert; Bruce M Psaty; John H M Austin; Jerry A Krishnan; Eric A Hoffman; Craig Johnson; Matthew J Budoff; Karol E Watson; R Graham Barr
Journal:  Respir Med       Date:  2016-12-08       Impact factor: 3.415

4.  The relationship between systolic pulmonary arterial pressure and Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with newly diagnosed chronic obstructive pulmonary disease.

Authors:  Ayhan Cosgun; Huseyin Oren; Mustafa Hamidullah Turkkani
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-11       Impact factor: 1.468

Review 5.  Continuous remote monitoring of COPD patients-justification and explanation of the requirements and a survey of the available technologies.

Authors:  Ivan Tomasic; Nikica Tomasic; Roman Trobec; Miroslav Krpan; Tomislav Kelava
Journal:  Med Biol Eng Comput       Date:  2018-03-05       Impact factor: 2.602

6.  Long QT and death in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease is not related to electrolyte disorders.

Authors:  Shani Zilberman-Itskovich; Eldad Rahamim; Faina Tsiporin-Havatinsky; Tomer Ziv-Baran; Ahuva Golik; Ronit Zaidenstein
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-20

7.  Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen Therapy.

Authors:  Maya Bisang; Tsogyal D Latshang; Sayaka S Aeschbacher; Fabienne Huber; Deborah Flueck; Mona Lichtblau; Stefanie Ulrich; Elisabeth D Hasler; Philipp M Scheiwiller; Silvia Ulrich; Konrad E Bloch; Michael Furian
Journal:  Front Med (Lausanne)       Date:  2021-03-01

8.  Altered Cardiac Repolarization in Chronic Obstructive Pulmonary Disease.

Authors:  Fatih Alper Uğuz; Fulsen Bozkuş; Ekrem Aksu; Nurhan Atilla; Hasan Kahraman; Adem Doğaner
Journal:  Turk Thorac J       Date:  2022-03

9.  Heart rate-corrected QT interval helps predict mortality after intentional organophosphate poisoning.

Authors:  Shou-Hsuan Liu; Ja-Liang Lin; Cheng-Hao Weng; Huang-Yu Yang; Ching-Wei Hsu; Kuan-Hsing Chen; Wen-Hung Huang; Tzung-Hai Yen
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  High prevalence of altered cardiac repolarization in patients with COPD.

Authors:  Noriane A Sievi; Christian F Clarenbach; Giovanni Camen; Valentina A Rossi; Arnoldus J R van Gestel; Malcolm Kohler
Journal:  BMC Pulm Med       Date:  2014-04-02       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.